Bevacizumab, a vascular endothelial growth factor inhibitor, promotes orthodontic tooth movement in an experimental rat model

OBJECTIVE: This study aimed to evaluate the impact of bevacizumab on orthodontic tooth movement (OTM) in Wistar rats. MATERIALS AND METHODS: The OTM model was constructed by placing an orthodontic coil spring between the maxillary first molar and anterior tooth. Bevacizumab (Avastin®; 10 mg/kg twice...

Descripción completa

Detalles Bibliográficos
Autores principales: Abuohashish, Hatem, Alamri, Abdulaziz, Shahin, Suliman, Almazrou, Dalal, Alkhamis, Taleb, Omar, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199243/
https://www.ncbi.nlm.nih.gov/pubmed/37215827
http://dx.doi.org/10.1016/j.heliyon.2023.e16217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199243/
https://www.ncbi.nlm.nih.gov/pubmed/37215827
http://dx.doi.org/10.1016/j.heliyon.2023.e16217

Ejemplares similares